Koji Asano Selected Research

flumioxazin

1/2022	Lack of human relevance for rat developmental toxicity of flumioxazin is revealed by comparative heme synthesis assay using embryonic erythroid cells derived from human and rat pluripotent stem cells.
1/2022	Flumioxazin, a PPO inhibitor: A weight-of-evidence consideration of its mode of action as a developmental toxicant in the rat and its relevance to humans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Koji Asano Research Topics

Disease

5	Neoplasms (Cancer) 05/2020 - 05/2003
3	Carcinoma (Carcinomatosis) 05/2020 - 05/2003
3	Prostatic Neoplasms (Prostate Cancer) 09/2005 - 02/2003
2	Anemia 01/2022 - 01/2022
1	Ventricular Heart Septal Defects (Ventricular Septal Defect) 01/2022
1	Acute Erythroblastic Leukemia (Erythroleukemia) 01/2022
1	Stomach Neoplasms (Stomach Cancer) 05/2020
1	Foreign-Body Reaction 04/2019
1	Hypoalbuminemia 02/2019
1	Neutropenia 02/2019
1	Hypertension (High Blood Pressure) 04/2013
1	Hyperaldosteronism (Conn Syndrome) 04/2013
1	Neoplasm Metastasis (Metastasis) 10/2012
1	Fibromyalgia (Fibrositis) 01/2012
1	Phyllodes Tumor (Cystosarcoma Phylloides) 04/2011
1	Stress Urinary Incontinence 03/2009
1	Infections 09/2005
1	Hepatocellular Carcinoma (Hepatoma) 05/2005
1	Lymphatic Metastasis 11/2003
1	Testicular Neoplasms (Testicular Cancer) 11/2003
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 11/2003
1	Urachal cancer 05/2003
1	Wounds and Injuries (Trauma) 03/2002

Drug/Important Bio-Agent (IBA)

2	Heme (Haem)IBA 01/2022 - 01/2022
2	flumioxazinIBA 01/2022 - 01/2022
2	AndrogensIBA 09/2005 - 05/2005
1	HerbicidesIBA 01/2022
1	Protoporphyrinogen Oxidase (Protox)IBA 01/2022
1	Antimalarials (Antimalarial Agents)IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	artenimol (dihydroartemisinin)IBA 01/2022
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 05/2020
1	LanthanumIBA 04/2019
1	cabazitaxel FDA Link 02/2019
1	Serum AlbuminIBA 02/2019
1	pegfilgrastim (Neulasta)FDA Link 02/2019
1	CreatinineIBA 04/2013
1	Hydrochloric Acid (Hydrogen Chloride)FDA Link 01/2012
1	Adrenergic Receptors (Adrenergic Receptor)IBA 03/2009
1	Etoposide (VP 16)FDA LinkGeneric 09/2005
1	SurvivinIBA 09/2005
1	Estrogens (Estrogen)FDA Link 05/2005
1	Diethylstilbestrol (Stilbestrol)FDA Link 05/2005
1	Androgen Receptors (Androgen Receptor)IBA 05/2005
1	Androgen Antagonists (Antiandrogens)IBA 05/2005
1	Hormones (Hormone)IBA 05/2005
1	OligodeoxyribonucleotidesIBA 11/2003
1	atelocollagenIBA 11/2003
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 11/2003
1	AntigensIBA 02/2003

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 10/2012 - 09/2005
3	Therapeutics 05/2005 - 03/2002
2	Cystectomy 07/2004 - 05/2003
1	Adrenalectomy 04/2013
1	Urinary Catheters 03/2002